Dr. Clay B. Siegall, Ph.D. has trained as a scientist focusing on targeted cancer therapies and is a Ph.D. holder of Genetics from Washington University. Dr. Clay Siegall is one of the founders of the Seattle Genetics company where he serves as the President and CEO. He was appointed as an outside director of the Mirna Therapeutics on 30th January 2013. Mirna is a biotechnology company that focuses on the commercialization and development of microRNA therapeutics. Mirna’s CEO expressed his excitement on Siegall’s appointment saying that his extensive experience and achievements in the establishment of Oncology Company were of great value to the Board and the entire Mina team.
The Seattle Genetics was established in 1998 by Clay Siegall. The company has built various pipeline antibody therapies that handle cancer and the related diseases. In August 2011, the first commercial product for Seattle Genetics the ADCETRIS (brentuximab vedotin) was approved. Seattle Genetics have partnered will some of the leading pharmaceutical and biotechnology companies in oncology. The company produces products for lung cancer, lymphoma, and myeloma. Today the company is enormously growing through its services to cure cancer. Dr. Clay Siegall has led Seattle Genetics into most activities to raise capital, and the company successfully made over 675 million dollars through private and public financing.
Dr. Clay Siegall has also worked as a Director in the Alder Biopharmaceuticals Board which is also a private biotechnology company. He served in the National Cancer Institute and the Bristol-Myers Squibb Pharmaceuticals Research since 1991 to 1997.
Dr. Clay’s great determination to offer the best cure for cancer was driven by the death of his father who was diagnosed with brain cancer. Dr. Clay saw the limited efficacy and the toxicity of the tools being used then and felt a great urge to create better cancer solution. Dr. Clay holds 15 patents and has authored over 70 publications and. His great determination to ensure a cancer-free world has earned him several awards in that field.